Bellicum Pharmaceuticals Profit Margin

The latest profit margin for BLCM is -1445.42% as of September 2023. That compares with -1025.33% in the prior-year period — down 41.0% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Bellicum Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, BLCM's profit margin moved from -1025.33% to -1445.42% — a 41.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bellicum Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, BLCM currently prints -1445.42% for profit margin, while the sector average sits near 9.48%. That is roughly 15345.5% below the sector mean. Large gaps often invite a closer look at Bellicum Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Bellicum Pharmaceuticals converts resources into returns. At -1445.42%, BLCM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1025.33% in the prior-year period — down 41.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BLCM's profit margin (-1445.42%), review year-over-year change from -1025.33%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.